Article Details
Retrieved on: 2024-03-18 21:37:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Made by Insilico Medicine, a biotechnology company based in New York and Hong Kong, the drug candidate targets idiopathic pulmonary fibrosis, a ...
Article found on: singularityhub.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here